BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/21/2020 4:02:08 PM | Browse: 634 | Download: 1021
 |
Received |
|
2020-05-27 05:42 |
|
Peer-Review Started |
|
2020-05-27 05:43 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-06-15 18:33 |
|
Revised |
|
2020-07-06 03:19 |
|
Second Decision |
|
2020-08-24 13:01 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-08-25 05:21 |
|
Articles in Press |
|
2020-08-25 05:21 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-09-18 02:38 |
|
Publish the Manuscript Online |
|
2020-09-21 16:02 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Biomarkers for hepatocellular cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Gurjot Singh, Eric M Yoshida, Sahaj Rathi, Vladimir Marquez, Peter Kim, Siegfried R Erb and Baljinder S Salh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Baljinder S Salh, FRCP, FRCP (C), MBChB, Associate Professor, Division of Gastroenterology, Department of Medicine, University of British Columbia, DHCC, 2775 Laurel Street, Vancouver V5Z 1M9, Canada. bill.salh@ubc.ca |
| Key Words |
Biomarkers; Hepatocellular carcinoma; Liver cancer; Cancer; Review; Serum |
| Core Tip |
The use of ultrasound with/without alpha-fetoprotein in the context of screening patients with chronic liver disease for the development of early stage hepatocellular carcinoma that is treatable, remains problematic. Consequently there has been considerable work done to examine biomarkers either individually, or in combination to address this deficiency. Whilst there are several promising targets (discussed in this manuscript) for this indication it appears that Gender, Age : Lens culinaris agglutinin-reactive of alpha-fetoprotein, Alpha-fetoprotein, and Des-γ-carboxy prothrombin, which has been established in Europe and Japan, and remains to be so in North America, may be clinically the best performer available. |
| Publish Date |
2020-09-21 16:02 |
| Citation |
Singh G, Yoshida EM, Rathi S, Marquez V, Kim P, Erb SR, Salh BS. Biomarkers for hepatocellular cancer. World J Hepatol 2020; 12(9): 558-573 |
| URL |
https://www.wjgnet.com/1948-5182/full/v12/i9/558.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v12.i9.558 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
